Ra Medical Systems (RMED) Misses Q1 EPS by 10c

Ra Medical Systems (NYSE: RMED) reported Q1 EPS of ($0.27), $0.10 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $100 thousand, versus $400 thousand reported last year.

Ra Medical reported cash and cash equivalents of $17.7 million as of March 31, 2022. In February 2022, the Company raised net proceeds of $9.7 million from a public offering after deducting offering costs paid and payable as of March 31, 2022.

For earnings history and earnings-related data on Ra Medical Systems (RMED) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Radnostix revenue falls 27% amid product recalls and FDA actions
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation